http://www.zibb.com/all/theme/cq/Angiotech+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 25 Nov 2009 21:03:00 GMTWed, 25 Nov 2009 21:03:00 GMT608831http://www.zibb.com/all/theme/cq/Angiotech+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.icongrouponline.com/pr/Angiotech_Pharmaceuticals_Inc_CA/PR.htmlSan Diego —-- Two of the most comprehensive vertical gap analysis and labor productivity benchmarks were released today by ICON Group International Ltd. on Angiotech Pharmaceuticals Inc (ANP).http://www.icongrouponline.com/pr/Angiotech_Pharmaceuticals_Inc_CA/PR.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.angio.com/news/The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.http://www.angio.com/news/Angiotech Pharmaceuticals Incorporatedhttp://www.quotelinks.com/companies/anpi.htmlStock quotes, news and charts for Angiotech Pharmaceuticals Inc Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stockhttp://www.quotelinks.com/companies/anpi.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.newratings.com/headlines/Angiotech-Pharmaceuticals_CA0349181028.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Angiotech-Pharmaceuticals_CA0349181028.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.biospace.com/news_by_disease_results.aspx?TheRxId=59920Completed Alltracel Pharmaceuticals Plc Pre-Clinical Studies Indicate Significant Longer Term Coronary Health Benefits Of The m.http://www.biospace.com/news_by_disease_results.aspx?TheRxId=59920Angiotech Pharmaceuticals Incorporatedhttp://www.canbiotech.com/home.asp?max_portlet=7&pId=14_32Participating on CanBiotech's Networks Using the Site Privacy & Security Statement Service Provider Spotlight/Showcase Guide Advertise with us Directory Guide & Access Policy News Postings Event Postings CanBiotech Newsletters © 2000-2009 CanBiotech™ Inc.http://www.canbiotech.com/home.asp?max_portlet=7&pId=14_32Angiotech Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=30448/CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has completed its acquisition of privately held Quill Medical, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=30448Angiotech Pharmaceuticals Incorporatedhttp://www.genzyme.com/corp/media/GENZ%20PR-050906.aspWe have detected that your browser does not have Javascript turned on. This site is optimized for Javascript. You may experience difficulties browsing certain parts of the site.http://www.genzyme.com/corp/media/GENZ%20PR-050906.aspAngiotech Pharmaceuticals Incorporatedhttp://www.researchandmarkets.com/reports/551590/isis_pharmaceuticals_inc_swot_analysisOur Isis Pharmaceuticals, Inc. Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.http://www.researchandmarkets.com/reports/551590/isis_pharmaceuticals_inc_swot_analysisAngiotech Pharmaceuticals Incorporatedhttp://www.ishareowner.com/csr/profile.cgi?id=3585Home | News | Reports | Marketplace | About Us | Contact | Tools | Login Corporate Social Research | Mutual Funds | Shareowner Action | Community Investment © SRI World Group, Inc.http://www.ishareowner.com/csr/profile.cgi?id=3585Angiotech Pharmaceuticals Incorporatedhttp://www.newsrx.com/newsletters/Pharma-Business-Week/2007-03-12/35031220071514PB.htmlReport 1: Angiotech Pharmaceuticals, Inc. (ANPI, ANP) announced that they received a favorable decision from a Dutch Court in a patent dispute against Conor Medsystems, Inc.http://www.newsrx.com/newsletters/Pharma-Business-Week/2007-03-12/35031220071514PB.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=92567&category=8Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=92567&category=8Angiotech Pharmaceuticals Incorporatedhttp://www.fasken.com/WEB/FMDWEBSITE.NSF/AllDocPrint/AEF5319AA2EDD12B8525719200781D07?OpenDocumentOn March 23, 2006 Angiotech Pharmaceuticals, Inc. closed the acquisition of American Medical Instruments Holdings, Inc. (AMI) for approximately US$785 million (C$900 million), subject to post-closing adjustments.http://www.fasken.com/WEB/FMDWEBSITE.NSF/AllDocPrint/AEF5319AA2EDD12B8525719200781D07?OpenDocumentAngiotech Pharmaceuticals Incorporatedhttp://www.theocc.com/market/infomemos/2003/mar/18796.htmThe Chicago Board Options Exchange ("CBOE") and the American Stock Exchange ("AMEX") have advised The Options Clearing Corporation ("OCC") that the Common Shares of Angiotech Pharmaceuticals, Inc. ("ANPI/AUJ") will split 2 for 1.http://www.theocc.com/market/infomemos/2003/mar/18796.htmAngiotech Pharmaceuticals Incorporatedhttp://www.newswire.ca/en/releases/archive/October2006/19/c2313.htmlVANCOUVER, Oct. 19 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the third quarter ended September 30, 2006.http://www.newswire.ca/en/releases/archive/October2006/19/c2313.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.qltinc.com/Qltinc/pages/pagespressdetail.cfm?PressID=77&YearRange=2000&InternetPageID=31QLT CEO NAMED ENTREPRENEUR OF THE YEAR, PACIFIC REGION DR. JULIA LEVY NOW ELIGIBLE FOR NATIONAL ENTREPRENEUR OF THE YEAR TITLE FOR IMMEDIATE RELEASE SEPTEMBER 29, 2000 Vancouver, Canada - Dr. Julia Levy, President and CEO of QLT Inc.http://www.qltinc.com/Qltinc/pages/pagespressdetail.cfm?PressID=77&YearRange=2000&InternetPageID=31Angiotech Pharmaceuticals Incorporatedhttp://www.investcom.com/cgi-bin/nameindustry/symbolsearch.cgi?ID=1&string=ANP&exact=yes&sym=yesAddress: 1618 Station Street, Vancouver, B.C., Canada V6A 1B6 O/S Shares: Approx. 84,100,000 Phone: (604) 221-7676 Fax: (604) 221-2330 Email: investor_relations@angio.com Contact: Dr.http://www.investcom.com/cgi-bin/nameindustry/symbolsearch.cgi?ID=1&string=ANP&exact=yes&sym=yesAngiotech Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=24519/CNW/ -- Angiotech Pharmaceuticals (Nasdaq: ANPI, TSX: ANP) today announced that it has closed the previously announced acquisition of American Medical Instruments Holdings, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=24519Angiotech Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=26868Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (Nasdaq: ANPI, TSX: ANP) announced today that they received a favorable decision from a Dutch court in a patent dispute against Sahajanand Medical Technologies Pvt. Ltd.http://www.pharmacychoice.com/News/article.cfm?Article_ID=26868Angiotech Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=12650/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP) today announced that it has entered into a definitive agreement to acquire Afmedica, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=12650Angiotech Pharmaceuticals Incorporatedhttp://www.researchandmarkets.com/reports/605392/angiotech_pharmaceuticals_inc_product.pdfThis report is an insightful source for data, analysis and strategic insights into a Angiotech Pharmaceuticals, Inc.’s pipeline and investigational products.http://www.researchandmarkets.com/reports/605392/angiotech_pharmaceuticals_inc_product.pdfAngiotech Pharmaceuticals Incorporatedhttp://www.researchandmarkets.com/reports/338541/drug_eluting_stents_global_strategic.pdfDescription: This report analyzes the worldwide markets for Drug-Eluting Stents in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2015.http://www.researchandmarkets.com/reports/338541/drug_eluting_stents_global_strategic.pdfAngiotech Pharmaceuticals Incorporatedhttp://www.neucoll.com/news/awards-accolades/Dr. Helen Burt's research laboratory in the University of British Columbia's Faculty of Pharmaceutical Sciences and Vancouver-based Angiotech Pharmaceuticals Inc.http://www.neucoll.com/news/awards-accolades/Angiotech Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=14392/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that it has completed its acquisition of Afmedica, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=14392Angiotech Pharmaceuticals Incorporatedhttp://www.researchandmarkets.com/reports/347947/coronary_stents_global_strategic_business.pdfDescription: This report analyzes the worldwide markets for Coronary Stents in US$ Million. The major product segments analyzed are Bare Metal Stents, and Drug Eluting Stents. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia Pacific, and Rest of World.http://www.researchandmarkets.com/reports/347947/coronary_stents_global_strategic_business.pdfAngiotech Pharmaceuticals Incorporated